Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients
出版年份 2019 全文链接
标题
Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-11-20
DOI
10.1002/ijc.32795
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types
- (2019) Anja van de Stolpe et al. Scientific Reports
- Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma
- (2019) W. van Boxtel et al. EUROPEAN JOURNAL OF CANCER
- Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on Tumoral heterogeneity and temporal concordance
- (2019) Bin Xu et al. HUMAN PATHOLOGY
- A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands
- (2018) Eline Boon et al. INTERNATIONAL JOURNAL OF CANCER
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression pattern of androgen receptor and AR-V7 in androgen deprivation therapy naïve salivary duct carcinomas
- (2018) Richard K. Yang et al. HUMAN PATHOLOGY
- Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas
- (2018) Jong Chul Park et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma
- (2018) Hideaki Takahashi et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
- (2017) Eline Boon et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma
- (2017) Wim van Boxtel et al. ORAL ONCOLOGY
- Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification
- (2017) Soichiro Takase et al. Oncotarget
- Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer
- (2016) M. G. Dalin et al. CLINICAL CANCER RESEARCH
- Reliable Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue Using Single Molecule Tags
- (2016) Astrid Eijkelenboom et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers
- (2015) Laura D. Locati et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Dutasteride and Enzalutamide Synergistically Suppress Prostate Tumor Cell Proliferation
- (2015) Agus Rizal A.H. Hamid et al. JOURNAL OF UROLOGY
- Knowledge-based computational models
- (2015) Wim Verhaegh et al. Oncotarget
- Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
- (2014) W. Verhaegh et al. CANCER RESEARCH
- Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications
- (2014) Y. Mitani et al. CLINICAL CANCER RESEARCH
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- (2011) C. Cai et al. CANCER RESEARCH
- Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
- (2011) K.-H. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started